UNITY Biotechnology Inc (UBX): About UNITY UNITY is developing a new c...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

UNITY Biotechnology Inc (UBX)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	1036
Posts	114652
Boards Moderated	13
Alias Born	06/10/2006

Re: None

Wednesday, 11/03/2021 10:23:52 AM

Wednesday, November 03, 2021 10:23:52 AM

About UNITY
UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter and LinkedIn.

It is understood that all posts on the site are to be considered opinions. They do not need to indicate this in their posts.

Readers determine the veracity of the posts they read and the credibility of other Users

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent UBX News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 09:05:13 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:05:23 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/11/2023 05:15:29 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/08/2023 09:39:06 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/06/2023 10:25:58 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 12:00:11 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 08:05:06 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 08:05:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2023 11:05:08 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/15/2023 08:08:25 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/15/2023 08:07:50 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 08:05:02 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 08:07:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 08:04:36 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 08:13:01 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/03/2023 08:13:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2023 08:05:34 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/01/2023 08:04:47 PM

More UBX News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow